INVO Fertility Inc IVF
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2008-11-11 |
| Shares Out. | 2,300,000 |
| Website | invofertility.com/ ↗ |
| Phone | 19788789505 |
| Employees | 46 |
| Revenue | $2.0M |
| Gross Profit | $727,826 |
| Net Income | -$5.5M |
| Free Cash Flow | -$5.4M |
| Total Assets | $24.7M |
| Total Liabilities | $9.6M |
| Equity | $15.0M |
About INVO Fertility Inc
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
INVO Fertility Inc is a publicly traded company under the ticker symbol IVF on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
5 analysts (2026-07-01)